NanoViricides Inc. (NNVC)

[JG36]

I never used $47,000 as the per patient cost of influenza phase III trials. I did say, as an off hand remark, that *some* drugs cost $47,000 per patient in the phase III trials, based upon a paper by the Manhattan Institute. I stand by that. The paper I referenced may be wrong, but that's what the paper said. So who is doing the B.S.ing here?

And while I never claimed that Flucide phase III trials would cost $47,000,000, even if I had, that's still a lot less than "hundreds of millions".